Search results
AstraZeneca withdraws Covid vaccine worldwide after admitting it can cause rare blood clots
The Independent via Yahoo News· 3 hours agoAstraZeneca is withdrawing its Covid-19 vaccine worldwide, months after the pharma giant admitted...
Elanco Makes A Bullish Move On Its First Quarter Beat; Are Pet Health Stocks Forging A Comeback?
Investor's Business Daily· 2 hours agoElanco stock gapped higher Wednesday after the pet drugmaker beat Wall Street's first quarter...
Teva Pharmaceutical’s stock climbs as schizophrenia treatment shows promise
Market Watch· 3 hours agoTeva Pharmaceutical Industries stock jumped more than 6% early Wednesday after the company reported...
AstraZeneca Withdraws Covid Vaccine As Demand Dives
International Business Times· 6 hours agoAnglo-Swedish drugmaker AstraZeneca on Wednesday said it was withdrawing Covid vaccine Vaxzevria, one of the first produced in the deadly pandemic,...
How One Drugmaker Plans To Cure Food Allergies
Bloomberg· 1 day agoHello, everyone. Damian in Miami here. Reputable drug companies usually shy away from throwing around the word “cure.” But one drugmaker is starting to...
Pfizer reports patient death in Duchenne gene therapy study
Reuters· 18 hours ago, opens new tab experimental gene therapy being tested in a mid-stage trial for a muscle-wasting...
At least 25,000 people in the US are starting weight-loss drug Wegovy each week, drugmaker says
CNN via Yahoo Finance· 6 days agoDrugmaker Novo Nordisk said it’s been increasing supply of its sought-after weight-loss drug Wegovy,...
Sanofi's New Cancer Drug Could Help Deliver a Big Payday
Motley Fool via Yahoo Finance· 2 hours agoSanofi expects its 2024 earnings per share to pull back a little before rebounding in 2025. The...
Teva Pharm to launch Humira biosimilar as Q1 profit misses estimates
Reuters via Yahoo Finance· 5 hours agoTeva Pharmaceutical Industries said it was set to launch its long awaited biosimilar of AbbVie's...
Heart Disease Drugmaker Esperion Therapeutics Reports Highest Revenue Yet, Stock Soars
Benzinga via Yahoo Finance· 1 day agoTuesday, Esperion Therapeutics (NASDAQ:ESPR) reported first-quarter revenues of $137.74 million, up...